Demographics (1)
- SEX - Annotated Sex (phv00555983.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte Type (phv00430065.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00430064.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00430055.v1.p1)
- Funding_Source - Project funding source (phv00430068.v1.p1)
- IS_TUMOR - Tumor status (phv00430066.v1.p1)
- SAMPLE_ID - Sample ID (phv00430063.v1.p1)
- SAMPLE_ID - Sample ID (phv00430060.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430067.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00430071.v1.p1)
- SUBJECT_ID - Subject ID (phv00430054.v1.p1)
- SUBJECT_ID - Subject ID (phv00430059.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00430069.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00430070.v1.p1)